Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Cyclin-dependent kinase 5 acts as a promising biomarker in clear cell Renal Cell Carcinoma

Fig. 1

The expression of CDK5 in kidney cancer. a The CDK5 expression among normal tissue and primary renal tumor in TCGA database, showed lower CDK5 expression in cancer tissues (p < 0.0001). b The CDK5 expression among kidney cancer and normal tissue in GENT database. c Ten paired fresh ccRCC samples were tested the CDK5 mRNA expression by using qRT-pcr (T means tumor tissue and N means matched normal tissue). d The protein levels of CDK5 were tested by western blot in same ccRCC samples. *p < 0.05

Back to article page